MarketScreener Homepage > Equities > Nasdaq > Guardant Health, Inc. GH

Report

Delayed Nasdaq - 01/27 04:00:00 pm
147.39	USD		-1.68%

01/27

GUARDANT HEALTH : Head-to-Head Study Shows Guardant360 Liquid Biopsy Outperforms Tissue Biopsy for Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer with Similar Outcomes

01/19

GUARDANT HEALTH : to Partner With Vall d'Hebron Institute of Oncology to Set Up First Liquid Biopsy Testing Service in Europe

01/18

GUARDANT HEALTH : and Vall d'Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe

News

Most relevant

Official Publications

Sector news

MarketScreener Strategies

Most relevant news about GUARDANT HEALTH, INC.

01/27	GUARDANT HEALTH : Head-to-Head Study Shows Guardant360 Liquid Biopsy Outperforms..	BU
01/19	GUARDANT HEALTH : to Partner With Vall d'Hebron Institute of Oncology to Set Up ..	MT
01/18	GUARDANT HEALTH : and Vall d'Hebron Institute of Oncology Announce Partnership t..	BU
01/14	GUARDANT HEALTH : to Present Data at ASCO Gastrointestinal Cancers Symposium Sho..	BU
01/11	GUARDANT HEALTH : Stifel Starts Guardant Health at Buy With $175 Price Target	MT
2020	GUARDANT HEALTH : to Participate in the 39th Annual J.P. Morgan Healthcare Confe..	BU
2020	GUARDANT HEALTH : AMEA Wins Frost & Sullivan's Market Leadership Award for Liqui..	AQ
2020	Guardant Health Names Michael Bell as CFO	MT
2020	GUARDANT HEALTH : Names Michael Bell as New Chief Financial Officer	BU
2020	GUARDANT HEALTH : SVB Leerink Adjusts Guardant Health's Price Target to $150 Fro..	MT
2020	GUARDANT HEALTH : Presents Data at San Antonio Breast Cancer Symposium Demonstra..	BU
2020	Guardant Health Prices Offering of $1 Billion in Convertible Senior Notes	MT
2020	GUARDANT HEALTH, INC. : Prices $1 Billion Convertible Senior Notes Offering	BU
2020	SECTOR UPDATE : Health Care Stocks Struggle Despite More Positive News for COVID..	MT
2020	SECTOR UPDATE : Health Care	MT
2020	UPDATE : Guardant Health Drops 9% in Wake of $1 Billion Convertible Senior Notes..	MT
2020	Guardant Health to Issue $1 Billion Worth of Convertible Senior Notes	MT
2020	GUARDANT HEALTH, INC. : Announces Proposed Convertible Senior Notes Offering	BU
2020	JP Morgan Adjusts Guardant Health's Price Target to $135 From $120, Maintains..	MT
2020	Morgan Stanley Adjusts Guardant Health PT to $130 From $110, Maintains Overwe..	MT
2020	Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Revenue $74.6M, vs. Street Est o..	MT
2020	GUARDANT HEALTH : 3Q Earnings Snapshot	AQ
2020	GUARDANT HEALTH : Reports Third Quarter 2020 Financial Results	BU
2020	GUARDANT HEALTH : Announces Webcast of Third Quarter Financial Results on Novemb..	BU
2020	GUARDANT HEALTH : Announces Closing of Public Offering of Common Stock, Includin..	BU
2020	GUARDANT HEALTH : Announces Pricing of Public Offering of Common Stock by Sellin..	BU
2020	GUARDANT HEALTH : Announces Proposed Public Offering of Common Stock by Selling ..	BU
2020	GUARDANT HEALTH : Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates ..	BU
2020	Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference	GL
2020	Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 ..	GL
2020	Guardant Health to Participate in Upcoming August Investor Conferences	GL
2020	GUARDANT HEALTH : Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehe..	AQ
2020	GUARDANT HEALTH : 2Q Earnings Snapshot	AQ
2020	Guardant Health Reports Second Quarter 2020 Financial Results	GL
2020	Guardant Health Announces Collaboration with Radius Health to Develop Liquid ..	GL
2020	Guardant Health Announces Webcast of Second Quarter Financial Results on Augu..	GL
2020	Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy..	GL
2020	Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate P..	GL
2020	Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liqui..	GL
2020	Guardant Health Appoints Vijaya Gadde to its Board of Directors	GL
2020	Guardant Health Announces Full Exercise of Option and Closing of Public Offer..	GL
2020	GUARDANT HEALTH : Announces Pricing of Upsized Public Offering	AQ
2020	Guardant Health Announces Proposed Public Offering of Common Stock	GL
2020	GUARDANT HEALTH : to Participate in the William Blair 2020 Growth Stock Conferen..	AQ
2020	Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Bi..	GL
2020	GUARDANT HEALTH : 1Q Earnings Snapshot	AQ
2020	Guardant Health Reports First Quarter 2020 Financial Results	GL
2020	Guardant Health to Participate in the BofA Securities 2020 Healthcare Confere..	GL
2020	Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of..	GL
2020	Guardant Health Presents Data at DDW Virtual Meeting Highlighting its Early C..	GL
2020	Guardant Health Announces Webcast of First Quarter Financial Results on May 7..	GL
2020	Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhi..	GL
2020	GUARDANT HEALTH : SEC Filing (S-3ASR)	PU
2020	GUARDANT HEALTH : 4Q Earnings Snapshot	AQ
2020	Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results a..	GL
2020	Guardant Health to Participate in Upcoming Investor Conferences	GL
2020	Guardant Health to Report Fourth Quarter and Full Year 2019 Financial Results..	GL
2020	Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information Offi..	GL
2020	Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid..	GL
2020	Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Cir..	GL
2019	Guardant Health to Present at the 38th Annual J.P. Morgan Healthcare Conferen..	GL
2019	Guardant Health Receives Expanded Medicare Coverage for Guardant360 Across th..	GL
2019	MASAYOSHI SON : SoftBank's Son says Japan should make AI mandatory subject for c..	RE
2019	Large-Scale Study Shows Guardant360 Effectively Guides Precision Oncology Tre..	GL
2019	Study Shows Only 40 Percent of Patients with Metastatic Colon Cancer Receive ..	GL
2019	GUARDANT HEALTH : New Global Survey Shows Misperceptions About Lung Cancer Among..	AQ
2019	Guardant Health Reports Third Quarter 2019 Financial Results and Raises 2019 ..	GL
2019	MASAYOSHI SON : SoftBank's Son admits mistakes after Vision Fund's $8.9 billion ..	RE
2019	Snakes and ladders - SoftBank Vision Fund's climbing, sliding valuations	RE
2019	Guardant Health to Report Third Quarter 2019 Financial Results on November 7,..	GL
2019	Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 Blood Test fo..	GL
2019	Data Presented at ESMO Show Metastatic CRC Patients with HER2 Amplification D..	GL
2019	Largest Study of its Kind Finds Guardant360 MSI Highly Concordant to Tissue	GL
2019	Guardant Health to Participate in Upcoming Investor Conferences	GL
2019	SoftBank to pump second Vision Fund with proceeds from the first - source	RE

1 2 Next

Upcoming event on GUARDANT HEALTH, INC.

03/16/21

FY 2020 Earnings Release (Projected)

Company calendar

Upcoming sector events

02/01/21	VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Release
02/02/21	BIO-TECHNE CORPORATION : Interim 2021 Earnings Release
02/03/21	QIAGEN N.V. : FY 2020 Earnings Release (Projected)
02/04/21	NEUROCRINE BIOSCIENCES, INC. : FY 2020 Earnings Release

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Biotechnology & Medical Research
			Biotechnology & Medical Research
				Bio Diagnostics & Testing